Ex VIvo DEtermiNed Cancer Therapy
Condition(s):Bladder Cancer; Kidney Cancer; Melanoma; Sarcoma; Glioblastoma; Head and Neck CancerLast Updated:June 18, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Bladder Cancer; Kidney Cancer; Melanoma; Sarcoma; Glioblastoma; Head and Neck CancerLast Updated:June 18, 2023Recruiting
Condition(s):ImmunotherapyLast Updated:July 20, 2021Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:November 13, 2023Not yet recruiting
Condition(s):Carcinoma, Renal CellLast Updated:January 31, 2024Recruiting
Condition(s):Complex Renal CystLast Updated:March 25, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 24, 2021Not yet recruiting
Condition(s):Urologic CancerLast Updated:March 21, 2024Recruiting
Condition(s):Breast Cancer; Bladder Cancer; Kidney Cancer; Colon Cancer; Prostate Cancer; Lung Cancer; Ovarian CancerLast Updated:April 4, 2023Recruiting
Condition(s):Metastatic Cancer; Melanoma Cancer; Lung Cancer; Bladder Cancer; Renal Cancer; Head/Neck CancersLast Updated:November 14, 2023Recruiting
Condition(s):Renal Cell Carcinoma; Clear Cell Renal Cell CarcinomaLast Updated:July 12, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.